These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2951833)

  • 1. [Phenytoin pharmacokinetics as a function of the preparation: capsules, commercial tablets and experimental tablets].
    Almaşu I; Leucuţa SE
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1986; 31(4):283-93. PubMed ID: 2951833
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study of phenytoin availability from pharmaceutical preparations].
    Leucuţa SE; Almaşu I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1986; 31(4):273-82. PubMed ID: 2951832
    [No Abstract]   [Full Text] [Related]  

  • 3. Phenytoin toxicity when tablets substituted for capsules.
    Kirshner HS
    N Engl J Med; 1983 May; 308(18):1106. PubMed ID: 6835331
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma phenytoin levels produced by various phenytoin preparations.
    Sansom LN; O'Reilly WJ; Wiseman CW; Stern LM; Derham J
    Med J Aust; 1975 Oct; 2(15):593-5. PubMed ID: 1105111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of serum phenytoin levels in epileptic patients who swallowed their phenytoin tablets with or without previous chewing.
    Bielmann P; Levac T
    Eur J Clin Pharmacol; 1978 Nov; 14(3):191-4. PubMed ID: 729613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose oral phenytoin loading.
    Osborn HH; Zisfein J; Sparano R
    Ann Emerg Med; 1987 Apr; 16(4):407-12. PubMed ID: 3826809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the bioavailability of Polfa phenytoin tablets].
    Lazowski J; Lypka A; Zadrozyńska E; Pakszys W
    Neurol Neurochir Pol; 1978; 12(3):251-5. PubMed ID: 683430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability and dissolution of proprietary and generic formulations of phenytoin.
    Soryal I; Richens A
    J Neurol Neurosurg Psychiatry; 1992 Aug; 55(8):688-91. PubMed ID: 1527539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phenytoin--blood levels and clinical aspects].
    Strandfjord RE; Johannessen SI
    Tidsskr Nor Laegeforen; 1973 Feb; 93(6):395-8. PubMed ID: 4698026
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of relative humidity on drug release from phenytoin sodium tablets and capsules. Part 1: Commercial preparations.
    Akbuğa J; Ari-Ulubelen A; Bayraktar-Alpmen G
    Pharmazie; 1984 Aug; 39(8):560-1. PubMed ID: 6504981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rational phenytoin therapy: a method for individualizing dosage].
    Wu JZ
    Zhonghua Yi Xue Za Zhi; 1986 Mar; 66(3):134-6, 188. PubMed ID: 3094864
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of phenytoin following intravenous administration in epileptic patients.
    Gatti G; Perucca E; Caravaggi M; Poloni M; Frigo GM; Crema A
    Farmaco Prat; 1977 Sep; 32(9):470-4. PubMed ID: 908442
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced seizure control due to spoiled phenytoin capsules.
    Cloyd JC; Gumnit RJ; Lesar TS
    Ann Neurol; 1980 Feb; 7(2):191-3. PubMed ID: 7369725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dynamics of the serum level increase of hydantoins following the begin of oral administration].
    Zouhar A; Hrazdira CL; Hrazdirová V; Skálová M
    Cesk Neurol Neurochir; 1975 May; 38(3):146-50. PubMed ID: 1132023
    [No Abstract]   [Full Text] [Related]  

  • 15. [Phenytoin determination in blood in epileptic children].
    Walther H; Meyer FP; Leuschner U
    Kinderarztl Prax; 1978 Jul; 46(7):364-74. PubMed ID: 682440
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ethnic differences in serum phenytoin levels].
    Dam M; Hübbe P; Christiansen J
    Ugeskr Laeger; 1974 Aug; 136(35):1974-6. PubMed ID: 4848674
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical significance of blood levels of diphenylhydantoin orally administered to epileptic patients].
    Ma ZZ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Jun; 18(3):136-8. PubMed ID: 4053817
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug estimation in the treatment of epilepsy.
    Richens A
    Proc R Soc Med; 1974 Dec; 67(12 Pt 1):1227-9. PubMed ID: 4449865
    [No Abstract]   [Full Text] [Related]  

  • 19. [The consequence of the preparation factors for the effect of the drug].
    Johnsgård M; Pedersen AO
    Tidsskr Nor Laegeforen; 1973 Apr; 93(10):698-703. PubMed ID: 4755086
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of blood levels of antiepileptic drugs in clinical practice.
    Kutt H
    Pediatrics; 1974 Apr; 53(4):557-60. PubMed ID: 4595906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.